Evidence map›Paper›PMID 41203769›Full record

ArticleScientific reports2025

Integrating ECG-derived features with conventional CVD risk models.

Maryam Mahdavi, Anoshirvan Kazemnejad, Abbas Asosheh, Davood Khalili, Kamyab Hosseinpour, Ahmadreza Tajari

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maryam MahdaviDepartment of Biostatistics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.ORCID https://orcid.org/0000-0002-8371-0694
Anoshirvan KazemnejadDepartment of Biostatistics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. kazem_an@modares.ac.ir.ORCID https://orcid.org/0000-0002-0143-9635
Abbas AsoshehDepartment of Medical Informatics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. asosheh@modares.ac.ir.ORCID https://orcid.org/0000-0002-5560-8238
Davood KhaliliPrevention of Metabolic Disorders Research Center, Research Institute for Metabolic and Obesity Disorders, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0003-4956-1039
Kamyab HosseinpourDepartment of Electrical Engineering, Sharif University of Technology, Tehran, Iran.
Ahmadreza TajariInstitute for Biological Information Processes (IBI), Molecular and Cellular Physiology (IBI-1), Forschungszentrum Jülich, Jülich, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-communicable diseases (NCDs), particularly cardiovascular diseases (CVDs), have become the leading cause of mortality worldwide, with Iran exhibiting higher-than-average incidence and mortality rates. Early detection of high-risk individuals is critical, as CVD often progresses silently. Electrocardiogram (ECG) signals may enhance risk prediction beyond Framingham risk score (FRS). This study aimed to evaluate the predictive performance of ECG signal features for incident CVD using signal processing in a large population-based cohort from the Tehran Lipid and Glucose Study (TLGS). A total of 4,637 adults aged 40 years devoid of past CVD at baseline (2006-2008) were followed up until 2018. Baseline characteristics, laboratory measurements, and ECG signal features were collected. CVD events were defined as coronary heart disease (CHD) or stroke. A recalibrated FRS (baseline) model assessed the association between ECG features and incident CVD, with model performance evaluated using Harrell's C-index, Net Reclassification Index (NRI), and Integrated Discrimination Improvement (IDI). Over a 10-year follow-up, 483 participants (10.4%) developed CVD. The introduction of ECG signal features improved risk prediction in women, increasing the Harrell's C-index from 0.84 to 0.85 and demonstrating significant reclassification improvement (NRI: 55.7%, IDI: 2.8%). However, no meaningful improvement was observed in men. ECG-based modeling outperformed FRS, particularly for intermediate-risk categories among women. Incorporating ECG signal features into risk models significantly enhanced CVD prediction performance in women, suggesting potential utility for improving individualized preventive strategies. Further research is warranted to refine ECG-based risk stratification tools for broader clinical application.

Indexed as

Cardiovascular DiseasesElectrocardiographyAdultFemaleHeart Disease Risk FactorsHumansIncidenceIranMaleMiddle AgedRisk AssessmentRisk FactorsCVDECG signalNRI and IDIPrediction model

Identifiers

PMID41203769
PMCPMC12594856

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.